Nasaleeze

Nasaleeze is a medical device developed and marketed by CEOLIA Pharma in Japan, where it was launched in 2022. It is a nasal mucosa protectant designed to form a physical barrier on the nasal lining, thereby preventing contact with allergens, dust, and other environmental irritants. The product is typically used to manage symptoms of allergic rhinitis and to protect the nasal cavity from external triggers. Unlike pharmacological treatments, Nasaleeze operates through a mechanical mechanism of action rather than a biochemical one, utilizing a powder that transforms into a gel-like layer upon contact with the moisture in the nasal passage.

Brand names

Nasaleezeナサリーズ

Other names

ナサリーズ